80 related articles for article (PubMed ID: 8604567)
1. The FDA review process: obtaining premarket approval for the PAPNET Testing System.
Mango LJ
Acta Cytol; 1996; 40(1):138-40. PubMed ID: 8604567
[No Abstract] [Full Text] [Related]
2. Computer-assisted rescreening of clinically important false negative cervical smears using the PAPNET Testing System.
Rosenthal DL; Acosta D; Peters RK
Acta Cytol; 1996; 40(1):120-6. PubMed ID: 8604564
[TBL] [Abstract][Full Text] [Related]
3. Rescreening of cervical Papanicolaou smears using PAPNET.
Koss LG
JAMA; 1998 Jun; 279(22):1786; author reply 1787-8. PubMed ID: 9628706
[No Abstract] [Full Text] [Related]
4. PAPNET automated screening.
Whittaker J; Cruse P; Denny L; Dehaeck K; Soeters R; Duffield M; Bloch B; Wranz P; MacCallum S
S Afr Med J; 1996 Mar; 86(3):273-4. PubMed ID: 8658306
[No Abstract] [Full Text] [Related]
5. Rescreening of cervical Papanicolaou smears using PAPNET.
Schechter CB
JAMA; 1998 Jun; 279(22):1787; author reply 1787-8. PubMed ID: 9628708
[No Abstract] [Full Text] [Related]
6. Rescreening of cervical Papanicolaou smears using PAPNET.
Mango LJ; Radensky PW
JAMA; 1998 Jun; 279(22):1786-7; author reply 1787-8. PubMed ID: 9628707
[No Abstract] [Full Text] [Related]
7. Simulation of primary cervical cancer screening by the PAPNET system in an unscreened, high-risk community.
Michelow PM; Hlongwane NF; Leiman G
Acta Cytol; 1997; 41(1):88-92. PubMed ID: 9022732
[TBL] [Abstract][Full Text] [Related]
8. Roche Image Analysis Systems, Inc.
Knesel EA
Acta Cytol; 1996; 40(1):60-6. PubMed ID: 8604576
[No Abstract] [Full Text] [Related]
9. Assessment of automated primary screening on PAPNET of cervical smears in the PRISMATIC trial. PRISMATIC Project Management Team.
Lancet; 1999 Apr; 353(9162):1381-5. PubMed ID: 10227217
[TBL] [Abstract][Full Text] [Related]
10. Preventing cervical cancer.
Ruskamp-Hatz J; Oliver L
NCSL Legisbrief; 2006; 14(44):1-2. PubMed ID: 17121201
[No Abstract] [Full Text] [Related]
11. Neuromedical Systems, Inc.
Mango LJ
Acta Cytol; 1996; 40(1):53-9. PubMed ID: 8604575
[No Abstract] [Full Text] [Related]
12. FDA panel conditionally approves DNA pap test without ACOG support.
Ostrzenski A
J Natl Med Assoc; 2002 Jun; 94(6):418. PubMed ID: 12078919
[No Abstract] [Full Text] [Related]
13. PAPNET for cervical cytology screening. Experience in Greece.
Veneti S; Papaefthimiou M; Symiakaki H; Ioannidou-Mouzaka L
Acta Cytol; 1999; 43(1):30-3. PubMed ID: 9987447
[TBL] [Abstract][Full Text] [Related]
14. Detection of unsuspected abnormalities by PAPNET-assisted review.
Mitchell H; Medley G
Acta Cytol; 1998; 42(1):260-4. PubMed ID: 9479349
[TBL] [Abstract][Full Text] [Related]
15. Reducing mortality due to cervical cancer. PAPNET fails the test.
Melnikow J; Nuovo J
Arch Fam Med; 1999; 8(1):56-7. PubMed ID: 9932073
[No Abstract] [Full Text] [Related]
16. Our journey towards improved accuracy in cytology: the role of new technologies.
Krieger P; Bibbo M
Acta Cytol; 1997; 41(1):11-4. PubMed ID: 9022720
[No Abstract] [Full Text] [Related]
17. [The PAPNET system in the rescreening of negative cervical/vaginal smears. A study from the Imola cytology laboratory].
Ghidoni D; Fabbris E; Folicaldi S; Amadori A; Medri M; Bucchi L; Bondi A
Pathologica; 1998 Aug; 90(4):357-63. PubMed ID: 9793395
[TBL] [Abstract][Full Text] [Related]
18. Monolayer slide preparation and automated slide reading systems for cervical cancer screening--clinical-effectiveness analysis.
Tecnologica MAP Suppl; 1998 Feb; ():34-9. PubMed ID: 10183359
[No Abstract] [Full Text] [Related]
19. Quality assurance in cervical cytology screening. Comparison of rapid rescreening and the PAPNET Testing System.
Halford JA; Wright RG; Ditchmen EJ
Acta Cytol; 1997; 41(1):79-81. PubMed ID: 9022730
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of PAPNET--a semiautomated system used in the screening against cervical cancer].
Hølund B; Ejersbo D; Hjortebjerg A
Ugeskr Laeger; 1998 Sep; 160(40):5802-6. PubMed ID: 9782761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
